Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person The transforming ability of ETV6-FLT3 fusion proteins is red...

Class:IdSummation:9703414
_displayNameThe transforming ability of ETV6-FLT3 fusion proteins is red...
_timestamp2020-10-07 18:27:56
created[InstanceEdit:9703419] Rothfels, Karen, 2020-10-06
modified[InstanceEdit:9704328] Rothfels, Karen, 2020-10-07
textThe transforming ability of ETV6-FLT3 fusion proteins is reduced in a GAB2 null background, implicating signaling through this GRB2-interactor as critical for the oncogenic program driven by the fusions (Chonabayashi et al, 2013).
(summation)[Reaction:9703440] FLT3 fusions:GRB2 bind GAB2 [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by The transforming ability of ETV6-FLT3 fusion proteins is red... (9703414)